{"id":"W2763770203","doi":"10.1093/annonc/mdx440.040","title":"Pembrolizumab (pembro) vs standard of care (SOC) for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): Phase 3 KEYNOTE-040 trial","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Population; Cetuximab; Internal medicine; Oncology; Head and neck cancer; Radiation therapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001337407,0.001174148,0.001486537,0.0002473109,0.0003297787,0.0009041938,0.0008416898,0.0009942254,0.007331241],"category_scores_gemma":[0.001059989,0.0004090662,0.001864308,0.0003078076,0.0006454176,0.001040656,0.0003587151,0.00307411,0.001168562],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00123898,"about_ca_system_score_gemma":0.001175946,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001902116,"about_ca_topic_score_gemma":0.005327322,"domain_scores_codex":[0.9997411,0.0001144982,0.00001075513,0.00005175608,0.00001917559,0.0000627007],"domain_scores_gemma":[0.9996154,0.00009777693,0.0000730141,0.00002827534,0.00002282209,0.0001626008],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8977196,0.008478635,0.001326831,0.001946964,0.002599629,0.0001060567,0.0001390121,0.001848742,0.007252448,0.0005532161,0.008992965,0.06903592],"study_design_scores_gemma":[0.9165272,0.07453361,0.003301584,0.00009670055,0.00101843,0.0001135986,0.00005283342,0.0006869683,0.0006764375,0.0004370113,0.002537172,0.00001856442],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9772362,0.00854679,0.0005840545,0.001609945,0.0005965488,0.001948243,0.002864672,0.0001928176,0.006420787],"genre_scores_gemma":[0.9818733,0.004414335,0.001415354,0.001754383,0.0002438447,0.001732669,0.002470648,0.00003623758,0.006059237],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007331241,"threshold_uncertainty_score":0.02452546,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1544250429091509,"score_gpt":0.4638174625534254,"score_spread":0.3093924196442746,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}